Cover Image

BRAF/MEK inhibitor-induced remission of primary cutaneous myoepithelial carcinoma after local recurrence

Saved in:

Bibliographic Details
Main Authors:	Jacqueline Guidry, MD (Author), Karl Lewis, MD (Author), Mariah Brown, MD (Author)
Format:	Book
Published:	Elsevier, 2020-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Multiple epidermotropic melanoma metastases developing during BRAF and MEK inhibitor therapy
by: Raphael Reinhard, MD, et al.
Published: (2018)

Clinical and economic analysis of treatment sequences with prolgolimab and BRAF/MEK inhibitors in adult patients with metastatic or unresectable cutaneous melanoma
by: S. K. Zyryanov, et al.
Published: (2024)

Combinatorial Therapies to Overcome BRAF/MEK Inhibitors Resistance in Melanoma Cells: An in vitro Study
by: Pópulo H, et al.
Published: (2021)

High BRAF V600 Mutation Level Associated with Worse Outcome in Metastatic Melanoma Patients Receiving BRAF and MEK Inhibitors
by: Ariane Fizazi, et al.
Published: (2024)

Clinico-economic analysis of PD-1 inhibitors and combinations of BRAF and MEK inhibitors for the treatment of metastatic melanoma with a BRAF V600 gene mutation
by: D. Yu. Belousov, et al.
Published: (2018)

Therapeutic Effectiveness of Immunoradiotherapy on Brain-metastatic BRAF/MEK Inhibitor-resistant Melanoma with Balloon Cell Change
by: Haruka Goto, et al.
Published: (2019)

Myoepithelial carcinoma of the posterior mediastinum: An uncommon site for a rare tumor
by: Eman Abdulfatah, M.D, et al.
Published: (2016)

Exacerbation of Multiple Sclerosis by BRAF/MEK Treatment for Malignant Melanoma: The Central Vein Sign to Distinguish Demyelinating Lesions From Metastases
by: Christopher C. Hemond MD, et al.
Published: (2021)

Epithelial-Myoepithelial Carcinoma of the Breast with Rhabdoid Features
by: Karl Grenier, et al.
Published: (2020)

Impressive clinical response following combined BRAF and MEK inhibition in a low-grade serous ovarian carcinoma patient with a BRAF V600E mutation
by: Anna Rodzajewska, et al.
Published: (2023)

A case of malignant transformation of a serous borderline ovarian tumor effectively treated with BRAF/MEK inhibitor combination
by: Manrose Singh, et al.
Published: (2024)

Locally recurrent primary cutaneous coccidioidomycosis
by: Gayin Lee, BA, et al.
Published: (2021)

Isotretinoin for the treatment of severe acneiform eruptions associated with the MEK inhibitor trametinib
by: Marco Caruana, MD, et al.
Published: (2020)

Clinical and Pathological Relevance of Drug-induced Vitiligo in Patients Treated for Metastatic Melanoma with Anti-PD1 or BRAF/MEK Inhibitors
by: Alice Ramondetta, et al.
Published: (2020)

Diagnostic dilemma in myoepithelial carcinoma of cheek
by: Yasmeen Khatib, et al.
Published: (2014)

Myoepithelial carcinoma of palate: Case report
by: Balakrishnan Thayumanavan, et al.
Published: (2014)

Recurrence of juvenile dermatomyositis 8 years after remission
by: Ken Muramatsu, MD, et al.
Published: (2017)

Response to re-challenge of a MEK inhibitor in a patient with recurrent low-grade serous carcinoma of the peritoneum
by: David M. Gershenson, et al.
Published: (2020)

BRAF L485-P490 deletion mutant metastatic melanoma sensitive to BRAF and MEK inhibition: A case report and literature review
by: Simeng Zhang, et al.
Published: (2023)

Indirect Comparison of Combined BRAF and MEK Inhibition in Melanoma Patients with Elevated Baseline Lactate Dehydrogenase
by: Valerie Glutsch, et al.
Published: (2020)

Cutaneous Side Effects of BRAF Inhibitors in Advanced Melanoma: Review of the Literature
by: Bilgen Gençler, et al.
Published: (2016)

Myoepithelial carcinoma of buccal mucosa: A rare tumor
by: Jeevan Lata, et al.
Published: (2014)

Clear cell myoepithelial carcinoma ex pleomorphic adenoma
by: Nikhil R Rabade, et al.
Published: (2014)

Sustained remission of recalcitrant cutaneous lymphoid hyperplasia after thalidomide treatment
by: Stephen P. Erickson, BS, et al.
Published: (2018)

Primary cutaneous anaplastic large-cell lymphoma: Complete remission for 13 years after denileukin diftitox
by: Daniel J. Lewis, BA, et al.
Published: (2017)

A diagnostic dilemma: Atypical melanocytic lesions arising in the setting of treatment with the BRAF inhibitor, vemurafenib
by: Mary Clark, MD, et al.
Published: (2022)

rearranged primary renal myoepithelial carcinoma: a diagnostic conundrum
by: Nilay Nishith, et al.
Published: (2023)

Soft tissue myoepithelial carcinoma: is it a low-grade cancer?
by: Lucas A. A. França, et al.

Response to MEK inhibitor in small cell neuroendocrine carcinoma of the cervix with a KRAS mutation
by: Yasmin A. Lyons, et al.
Published: (2014)

Myoepithelial cells in pathology
by: N Balachander, et al.
Published: (2015)

MEK inhibitors for the treatment of NRAS mutant melanoma
by: Sarkisian S, et al.
Published: (2018)

Metastatic Parotid Myoepithelial Carcinoma in a 7-Year-Old Boy
by: Issam Saliba, et al.
Published: (2012)

SMARCB1-deficient myoepithelial carcinoma of the lung: A case report
by: Makoto Yoshida, et al.
Published: (2020)

Epithelial-Myoepithelial Carcinoma of the Palate: Report of a Case and Review of the Literatures
by: Nazanin Mahdavi, et al.
Published: (2020)

Durable response to BRAF inhibitor monotherapy in recurrent metastatic low grade serous ovarian cancer
by: Shashank Sama, et al.
Published: (2024)

Cutaneous sarcoidosis due to immune‐checkpoint inhibition and exacerbated by a novel BRAF dimerization inhibitor
by: J. P. Pham, et al.
Published: (2021)

First-Line Use of Vemurafenib to Enable Thyroidectomy and Radioactive Iodine Ablation for BRAF-Positive Metastatic Papillary Thyroid Carcinoma
by: Bao D. Dao MD, et al.
Published: (2015)

The use of pulling sutures for surgical excision of soft palatal epithelial-myoepithelial carcinoma
by: Ciro Emiliano Boschetti, et al.
Published: (2022)

Rare Development of Primary Parotid Gland Epithelial-Myoepithelial Carcinoma in a Child
by: Daniyah Saleh, et al.
Published: (2020)

Infiltrating myoepithelial carcinoma of the breast, a case report and cytologic-histologic correlation
by: Kure Kiyoe, et al.
Published: (2008)